Drug designing is the process of finding new medications for a disease or disorder based upon the available knowledge of biomolecular drug targets
The drug is a small molecule, most commonly an organic molecule. It results in a therapeutic effect on the affected patient by activating or inactivating the molecular function of a biomolecule. That biomolecule will be a protein in most cases.
Generally, traditional drug designing is a time-consuming and highly cost-effective process.
It will take roughly 10-15 years and 500-800 million USD for the formulation of one successful drug into the market.
Incorporating computers and several computational techniques will reduce the time and cost of the traditional drug designing process.